Development of a new bicistronic retroviral vector with strong IRES activity
<p>Abstract</p> <p>Background</p> <p>Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expre...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-01-01
|
| Series: | BMC Biotechnology |
| Online Access: | http://www.biomedcentral.com/1472-6750/6/4 |
| _version_ | 1818758305610203136 |
|---|---|
| author | Boulukos Kim E Poggi Marie Albagli Olivier Martin Patrick Pognonec Philippe |
| author_facet | Boulukos Kim E Poggi Marie Albagli Olivier Martin Patrick Pognonec Philippe |
| author_sort | Boulukos Kim E |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expression of a protein whose biological function is being investigated through the observation of an easily detectable tracer, such as Green Fluorescent Protein (GFP). However, analysis of published results making use of bicistronic vectors indicates that the efficiency of the IRES-controlled expression can vary widely from one vector to another, despite their apparent identical IRES sequences. We investigated the molecular basis for these discrepancies.</p> <p>Results</p> <p>We observed up to a 10 fold difference in IRES-controlled expression from distinct bicistronic expression vectors harboring the same apparent IRES sequences. We show that the insertion of a HindIII site, in place of the initiating AUG codon of the wild type EMCV IRES, is responsible for the dramatic loss of expression from the second cistron, whereas expression from the first cistron remains unaffected. Thus, while the replacement of the authentic viral initiating AUG by a HindIII site results in the theoretical usage of the initiation codon of the HindIII-subcloned cDNA, the subsequent drop of expression dramatically diminishes the interest of the bicistronic structure. Indeed, insertion of the HindIII site has such a negative effect on IRES function that detection of the IRES-controlled product can be difficult, and sometimes even below the levels of detection. It is striking to observe that this deleterious modification is widely found in available IRES-containing vectors, including commercial ones, despite early reports in the literature stating the importance of the integrity of the initiation codon for optimal IRES function.</p> <p>Conclusion</p> <p>From these observations, we engineered a new vector family, pPRIG, which respects the EMCV IRES structure, and permits easy cloning, tagging, sequencing, and expression of any cDNA in the first cistron, while keeping a high level of expression from its IRES-dependent second cistron (here encoding eGFP).</p> |
| first_indexed | 2024-12-18T06:24:43Z |
| format | Article |
| id | doaj.art-ff278b45f4034834ae73faaaaa7d3caa |
| institution | Directory Open Access Journal |
| issn | 1472-6750 |
| language | English |
| last_indexed | 2024-12-18T06:24:43Z |
| publishDate | 2006-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Biotechnology |
| spelling | doaj.art-ff278b45f4034834ae73faaaaa7d3caa2022-12-21T21:18:04ZengBMCBMC Biotechnology1472-67502006-01-0161410.1186/1472-6750-6-4Development of a new bicistronic retroviral vector with strong IRES activityBoulukos Kim EPoggi MarieAlbagli OlivierMartin PatrickPognonec Philippe<p>Abstract</p> <p>Background</p> <p>Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expression of a protein whose biological function is being investigated through the observation of an easily detectable tracer, such as Green Fluorescent Protein (GFP). However, analysis of published results making use of bicistronic vectors indicates that the efficiency of the IRES-controlled expression can vary widely from one vector to another, despite their apparent identical IRES sequences. We investigated the molecular basis for these discrepancies.</p> <p>Results</p> <p>We observed up to a 10 fold difference in IRES-controlled expression from distinct bicistronic expression vectors harboring the same apparent IRES sequences. We show that the insertion of a HindIII site, in place of the initiating AUG codon of the wild type EMCV IRES, is responsible for the dramatic loss of expression from the second cistron, whereas expression from the first cistron remains unaffected. Thus, while the replacement of the authentic viral initiating AUG by a HindIII site results in the theoretical usage of the initiation codon of the HindIII-subcloned cDNA, the subsequent drop of expression dramatically diminishes the interest of the bicistronic structure. Indeed, insertion of the HindIII site has such a negative effect on IRES function that detection of the IRES-controlled product can be difficult, and sometimes even below the levels of detection. It is striking to observe that this deleterious modification is widely found in available IRES-containing vectors, including commercial ones, despite early reports in the literature stating the importance of the integrity of the initiation codon for optimal IRES function.</p> <p>Conclusion</p> <p>From these observations, we engineered a new vector family, pPRIG, which respects the EMCV IRES structure, and permits easy cloning, tagging, sequencing, and expression of any cDNA in the first cistron, while keeping a high level of expression from its IRES-dependent second cistron (here encoding eGFP).</p>http://www.biomedcentral.com/1472-6750/6/4 |
| spellingShingle | Boulukos Kim E Poggi Marie Albagli Olivier Martin Patrick Pognonec Philippe Development of a new bicistronic retroviral vector with strong IRES activity BMC Biotechnology |
| title | Development of a new bicistronic retroviral vector with strong IRES activity |
| title_full | Development of a new bicistronic retroviral vector with strong IRES activity |
| title_fullStr | Development of a new bicistronic retroviral vector with strong IRES activity |
| title_full_unstemmed | Development of a new bicistronic retroviral vector with strong IRES activity |
| title_short | Development of a new bicistronic retroviral vector with strong IRES activity |
| title_sort | development of a new bicistronic retroviral vector with strong ires activity |
| url | http://www.biomedcentral.com/1472-6750/6/4 |
| work_keys_str_mv | AT boulukoskime developmentofanewbicistronicretroviralvectorwithstrongiresactivity AT poggimarie developmentofanewbicistronicretroviralvectorwithstrongiresactivity AT albagliolivier developmentofanewbicistronicretroviralvectorwithstrongiresactivity AT martinpatrick developmentofanewbicistronicretroviralvectorwithstrongiresactivity AT pognonecphilippe developmentofanewbicistronicretroviralvectorwithstrongiresactivity |